CLERA INC has a total of 42 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are MOTAC NEUROSCIENCE LTD, CALISTOGA PHARMACEUTICALS INC and ELLIPSES PHARMA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Australia | 3 | |
#5 | China | 3 | |
#6 | Mexico | 3 | |
#7 | New Zealand | 3 | |
#8 | United States | 3 | |
#9 | Brazil | 2 | |
#10 | Israel | 2 | |
#11 | Republic of Korea | 2 | |
#12 | United Kingdom | 1 | |
#13 | Norway | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Seeman Philip | 34 |
#2 | Toleikis Philip M | 7 |
#3 | Philip Seeman | 4 |
#4 | Seeman Phillip | 1 |
Publication | Filing date | Title |
---|---|---|
AU2010278645A1 | Compositions and methods for treating Parkinson's disease | |
CN101983058A | Compositions and methods for alleviating depression or improving cognition | |
WO2007118325A1 | Enhancement of memory and/or cognition using substituted butyrophenone compounds | |
WO2007095756A1 | Novel central-nervous system acting compounds and methods for the treatment of cns disorders | |
WO2007076601A1 | Imaging of d2high receptors using radiolabelled (-)- quinpirole and analogs thereof | |
EP1874730A1 | Substituted butyrophenone derivatives | |
WO2006084368A1 | Fluorinated phno and analogs thereof | |
CA2628298A1 | Method to detect dopamine receptors in the functional d2high state | |
GB0228610D0 | Benzamide derivatives |